相关实验视频
Updated: Jul 12, 2025

07:58
Cell-Free DNA Integrity Analysis in Urine Samples
Published on: January 5, 2017
13.8K
一个转录组研究的p53-通路相关的预后基因签名设置在膀癌的转录组研究
Safayat Mahmud Khan1, Tonmoy Das2, Sajib Chakraborty2
1Clinical Biochemistry and Translational Medicine Laboratory, Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh.
Heliyon
|October 25, 2023
概括
这项研究基于p53通路基因确定了两个膀癌 (BLCA) 亚型. 一个亚型显示与免疫相关的预后不佳,而另一个亚型与类固醇合成和药物代谢相关的结果更好.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 在癌症的发展中,p53通路至关重要.
- 在膀癌 (BLCA) 中,p53通路基因的作用仍未得到充分研究.
- 了解这些遗传作用可以揭示新的治疗点.
研究的目的:
- 研究p53通路基因在肌肉侵入性膀癌 (BLCA) 中的作用.
- 根据p53通路基因表达来识别不同的BLCA亚型.
- 开发一种潜在的BLCA诊断或预后生物标志物.
主要方法:
- 利用了来自癌症基因组图谱 (TCGA) 的411名肌肉侵入性BLCA患者的转录组学数据.
- 应用非负矩阵因子化 (NMF) 来识别基于标志性p53通路基因组的亚型.
- 进行了临床,生存,免疫学和通路丰富分析,以表征亚型.
- 开发了一种特征基因组和风险模型,验证了10名BLCA患者血液和瘤组织中的基因表达.
主要成果:
- 根据p53通路基因表达,确定了两个不同的BLCA亚型 (C1和C2).
- 亚型C1 (预后不佳) 显示免疫相关途径的丰富.
- C2亚型 (更好的预后) 在类固醇合成和药物代谢途径方面得到了丰富.
- 一个特征基因组 (MDGA2, GNLY, GGT2, UGT2B4, DLX1, DSC1) 被开发出来.
- 在血液和瘤组织之间观察到DSC1表达的显著差异 (p=0.005).
- 与血液相比,DLX1表达在瘤组织中较低 (p=0.02734).
结论:
- 这项研究为膀癌提供了第一个与p53通路相关的基因特征.
- 确定了具有不同预后和途径丰富的独特BLCA亚型.
- 已识别的特征基因,特别是DSC1和DLX1,显示出可能成为BLCA的新生物标志物.
- 对这些生物标志物的进一步研究可能会对BLCA诊断和治疗产生重大影响.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K

